Literature DB >> 25268299

Establishing a quantitative benchmark for morbidity in pancreatoduodenectomy using ACS-NSQIP, the Accordion Severity Grading System, and the Postoperative Morbidity Index.

Charles M Vollmer1, Russell S Lewis, Bruce L Hall, John D Allendorf, Joal D Beane, Stephen W Behrman, Mark P Callery, John D Christein, Jeffrey A Drebin, Irene Epelboym, Jin He, Henry A Pitt, Emily Winslow, Christopher Wolfgang, Steven M Strasberg.   

Abstract

OBJECTIVE: The study aim was to quantify the burden of complications of pancreatoduodenectomy (PD).
BACKGROUND: The Postoperative Morbidity Index (PMI) is a quantitative measure of the average burden of complications of a procedure. It is based on highly validated systems--ACS-NSQIP and the Modified Accordion Severity Grading System.
METHODS: Nine centers contributed ACS-NSQIP complication data for 1589 patients undergoing PD from 2005 to 2011. Each complication was assigned a severity weight ranging from 0.11 for the least severe complication to 1.00 for postoperative death, and PMI was derived. Contribution to total burden by each complication grade was used to generate a severity profile ("spectrogram") for PD. Associations with PMI were determined by regression analysis.
RESULTS: ACS-NSQIP complications occurred in 528 cases (33.2%). The non-risk-adjusted PMI was 0.115 (SD = 0.023) for all centers and 0.113 (SD = 0.005) for the 7 centers that contributed at least 100 cases. Grade 2 complications were predominant in frequency, and the most common complication was postoperative bleeding/transfusion. Frequency and burden of complications differed markedly. For instance, severe complications (grades 4/5/6) accounted for only about 20% of complications but for more than 40% of the burden of complications. Organ space infection had the highest burden of any complication. The average burden in cases in which a complication actually occurred was 0.346.
CONCLUSIONS: This study develops a quantitative non-risk-adjusted benchmark for postoperative morbidity of PD. The method quantifies the burden of types and grades of postoperative complications and should prove useful in identifying areas that require quality improvement.

Entities:  

Mesh:

Year:  2015        PMID: 25268299     DOI: 10.1097/SLA.0000000000000843

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  26 in total

1.  Quantifying the burden of complications following total pancreatectomy using the postoperative morbidity index: a multi-institutional perspective.

Authors:  Jashodeep Datta; Russell S Lewis; Steven M Strasberg; Bruce L Hall; John D Allendorf; Joal D Beane; Stephen W Behrman; Mark P Callery; John D Christein; Jeffrey A Drebin; Irene Epelboym; Jin He; Henry A Pitt; Emily Winslow; Christopher Wolfgang; Major K Lee; Charles M Vollmer
Journal:  J Gastrointest Surg       Date:  2014-12-02       Impact factor: 3.452

2.  Externalized Stents for Pancreatoduodenectomy Provide Value Only in High-Risk Scenarios.

Authors:  Matthew T McMillan; Brett L Ecker; Stephen W Behrman; Mark P Callery; John D Christein; Jeffrey A Drebin; Douglas L Fraker; Tara S Kent; Major K Lee; Robert E Roses; Michael H Sprys; Charles M Vollmer
Journal:  J Gastrointest Surg       Date:  2016-10-11       Impact factor: 3.452

3.  Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial.

Authors:  Stefano Andrianello; Giovanni Marchegiani; Giuseppe Malleo; Gaia Masini; Alberto Balduzzi; Salvatore Paiella; Alessandro Esposito; Luca Landoni; Luca Casetti; Massimiliano Tuveri; Roberto Salvia; Claudio Bassi
Journal:  JAMA Surg       Date:  2020-04-01       Impact factor: 14.766

4.  Robotic versus open pancreaticoduodenectomy: a meta-analysis of short-term outcomes.

Authors:  Qing Yan; Lei-Bo Xu; Ze-Fang Ren; Chao Liu
Journal:  Surg Endosc       Date:  2019-12-17       Impact factor: 4.584

5.  Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies.

Authors:  Brett L Ecker; Matthew T McMillan; Laura Maggino; Valentina Allegrini; Horacio J Asbun; Chad G Ball; Claudio Bassi; Joal D Beane; Stephen W Behrman; Adam C Berger; Mark Bloomston; Mark P Callery; John D Christein; Euan Dickson; Elijah Dixon; Jeffrey A Drebin; Carlos Fernandez-Del Castillo; William E Fisher; Zhi Ven Fong; Ericka Haverick; Robert H Hollis; Michael G House; Steven J Hughes; Nigel B Jamieson; Tara S Kent; Stacy J Kowalsky; John W Kunstman; Giuseppe Malleo; Ronald R Salem; Kevin C Soares; Vicente Valero; Ammara A Watkins; Christopher L Wolfgang; Amer H Zureikat; Charles M Vollmer
Journal:  J Gastrointest Surg       Date:  2017-08-24       Impact factor: 3.452

6.  National Trends in Robotic Pancreas Surgery.

Authors:  Richard S Hoehn; Ibrahim Nassour; Mohamed A Adam; Sharon Winters; Alessandro Paniccia; Amer H Zureikat
Journal:  J Gastrointest Surg       Date:  2020-04-20       Impact factor: 3.452

7.  Assessment of complications after liver surgery: Two novel grading systems applied to patients undergoing hepatectomy.

Authors:  Li-Ning Xu; Bo Yang; Gui-Ping Li; De-Wei Gao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

8.  A novel risk scoring system reliably predicts readmission after pancreatectomy.

Authors:  Vicente Valero; Joshua C Grimm; Arman Kilic; Russell L Lewis; Jeffrey J Tosoian; Jin He; James F Griffin; John L Cameron; Matthew J Weiss; Charles M Vollmer; Christopher L Wolfgang
Journal:  J Am Coll Surg       Date:  2015-01-08       Impact factor: 6.113

9.  A Propensity Score-Matched Analysis of Robotic vs Open Pancreatoduodenectomy on Incidence of Pancreatic Fistula.

Authors:  Matthew T McMillan; Amer H Zureikat; Melissa E Hogg; Stacy J Kowalsky; Herbert J Zeh; Michael H Sprys; Charles M Vollmer
Journal:  JAMA Surg       Date:  2017-04-01       Impact factor: 14.766

Review 10.  Recent Advances in Pancreatic Cancer Surgery.

Authors:  Laura Maggino; Charles M Vollmer
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.